Search for: "D. Kappos"
Results 221 - 240
of 273
Sorted by Relevance
|
Sort by Date
16 Jun 2010, 3:02 pm
Kappos (Patent Docs) Niaspan (Niacin) – US: Patent infringement complaint filed following a Paragraph IV certification: Abbott Laboratories et al. v. [read post]
10 Mar 2015, 8:49 am
Berry (Cooley); Ralph D. [read post]
6 Jun 2011, 6:49 am
As noted by USPTO Director, David Kappos, “there has been concern in the independent inventor community that the new process will make it easier for an interloper to learn of your invention and beat you to the patent office with an application. [read post]
2 Jul 2014, 7:29 am
[…]Id. at *21 (internal citations omitted).d. [read post]
24 Oct 2010, 11:48 pm
(Chicago IP Litigation Blog) District Court N D Illinois: Court will not rewrite claims to avoid nonsensical results: Viskase Cos., Inc. v. [read post]
19 Jul 2010, 12:25 am
Kappos (Awaken IP) District Court N D Illinois: False marking claims not barred by earlier-filed case involving the same clients: Simonian v. [read post]
26 Oct 2009, 5:25 am
Medico (Filewrapper) BPAI finds claim indefinite and not directed to patentable subject under Bilski: Ex parte Hemmat (GRAY On Claims) District Court N D Illinois: KSR obviousness does not require prior art from the same field: Se-Kure Controls, Inc v Diam USA, Inc (Chicago Intellectual Property Law Blog) District Court E D Texas finds plaintiff has standing; agreement transfers ownership and simultaneously a conditional purchase by transferor from transferee: Balsam Coffee… [read post]
26 Oct 2009, 5:25 am
Medico (Filewrapper) BPAI finds claim indefinite and not directed to patentable subject under Bilski: Ex parte Hemmat (GRAY On Claims) District Court N D Illinois: KSR obviousness does not require prior art from the same field: Se-Kure Controls, Inc v Diam USA, Inc (Chicago Intellectual Property Law Blog) District Court E D Texas finds plaintiff has standing; agreement transfers ownership and simultaneously a conditional purchase by transferor from transferee: Balsam Coffee… [read post]
19 Jun 2014, 4:14 pm
In short, each step does no more than require a generic computer to perform generic computer functions.Id. at *15.Considering Elements as an Ordered CombinationConsidered “as an ordered combination,” the computer components of petitioner’s method “ad[d] nothing . . . that [read post]
4 May 2010, 9:03 am
I know this is an open-ended question, and maybe you can take it where you’d like. [read post]
7 Dec 2009, 3:00 am
(IP Law Blog) (IP Law Blog) US Patents David Kappos and the impact of KSR – a unique opportunity for our profession (Patently-O) Patent litigation insurance: good for the defendant, better for the insurer (PatLit) ED Patent filings update/another Federal Circuit venue opinion (EDTexweblog.com) Google creates its own dictionary – will it be used by patent practitioners? [read post]
14 Sep 2009, 5:51 am
Castro v Cartwright (TTABlog) TTAB reverses 2(e)(2) refusal of PROFUMO DE FIRENZE for perfume, finding double entendre: In re Atelier Profumo Artistico Firenze SrL (not precedential) (TTABlog) TTAB affirms failure-to-function refusal of STRENGTH IN DATA for brochures: In re ImClone Systems Incorporated (not precedential) (TTABlog) TTAB affirms 2(d) r [read post]
8 Jun 2009, 2:00 am
(Excess Copyright) (IPKat) (Ars Technica) (IAM) (Intellectual Property Watch) (Technology Transfer Tactics) (The IP Factor) (Patent Baristas) (ISinIP) (Managing Intellectual Property) GSK, Tafas file petitions for rehearing in Tafas v Doll (Patent Docs) (Patent Docs) (Peter Zura's 271 Patent Blog) (Patently-O) (Inventive Step) (IP Watchdog) Entire Federal Circuit hears argument on whether 271(f) applies to method claims: Cardiac Pacemakers v St Jude Medical (Inventive Step) District Court E… [read post]
8 Jun 2009, 2:00 am
(Excess Copyright) (IPKat) (Ars Technica) (IAM) (Intellectual Property Watch) (Technology Transfer Tactics) (The IP Factor) (Patent Baristas) (ISinIP) (Managing Intellectual Property) GSK, Tafas file petitions for rehearing in Tafas v Doll (Patent Docs) (Patent Docs) (Peter Zura's 271 Patent Blog) (Patently-O) (Inventive Step) (IP Watchdog) Entire Federal Circuit hears argument on whether 271(f) applies to method claims: Cardiac Pacemakers v St Jude Medical (Inventive Step) District Court E… [read post]
27 May 2010, 3:20 am
Lupin Pharma (Patent Baristas) Metvixia (Methyl aminolevulinate) – US: Structurally similar drug with different biological properties meets criteria for term extension: Photocure ASA v Kappos (Patent Baristas) Mirapex (Pramipexole) – US: Patent infringement complaint based on ANDA filing: Sandoz Inc. v. [read post]
7 Sep 2012, 5:21 am
Finally, although expensive, a § 145 civil action can reset the entire record and remove all deference (see the recent Kappos v. [read post]
2 Sep 2014, 2:40 pm
Supp. 2d 1120 (D. [read post]
29 Dec 2010, 2:57 am
General Nations closer to pandemic vaccine framework, key negotiator says (IP Watch) Differences in ratio of deaths to new cases for 6 cancer types in 14 WHO regions, with reference to income of region (KEI) Australia: Australian Senate inquiry seeks submissions on ‘gene patent’ amendments (Patentology) (ipwars.com) EU: A chance to comment on the Yeda reference, but you’d better be quick (The SPC Blog) EU: The word is out: Patenting plant breeding methods – G… [read post]
12 Aug 2011, 5:13 pm
Kappos, finding that the method claims were not tied to a particular machine and also failed to transform an article to a different state or thing. [read post]
3 Jun 2014, 7:49 am
Kappos – would have underscored the risks of offering such a vague and unspecified piece of guidance as this. [read post]
